US$ 21.73
anela protocol klow Buy Klow Blend Buy KLOW Peptide Blend |
Description
The non-overlapping specificities of GLS1 inhibitors and -lap for PDA tumors afford high tumor selectivity, while sparing normal tissue

Source : Watanabe F., et al

L., Lin, M

PMCID: PMC7114772

ReadiSorb was founded by a medical doctor and has been trusted by healthcare providers for over two decades
